Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY).

Tanioka H, Nagasaka T, Uno F, Inoue M, Okita H, Katata Y, Kanzaki H, Kuramochi H, Satake H, Shindo Y, Doi A, Nasu J, Yamashita H, Yamaguchi Y.

BMC Cancer. 2019 Oct 11;19(1):941. doi: 10.1186/s12885-019-6163-6.

PMID:
31604467
2.

Multicenter phase II study of biweekly CAPIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer (JSWOG-C3 study).

Suzuki N, Hazama S, Nagasaka T, Tanioka H, Iwamoto Y, Negoro Y, Yamauchi M, Kobayashi M, Okuda H, Fujishima N, Nishimura T, Yamanaka N, Toyota K, Mori Y, Nakagami Y, Shimokawa M, Nagano H, Okajima M.

Int J Clin Oncol. 2019 Oct;24(10):1223-1230. doi: 10.1007/s10147-019-01473-3. Epub 2019 May 29.

3.

Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety.

Tanioka H, Honda M, Tanaka C, Morita Y, Ishibashi K, Kato T, Matsuda C, Kataoka M, Satake H, Munemoto Y, Kobayashi K, Takahashi M, Nakata K, Sakamoto J, Oba K, Mishima H.

Int J Clin Oncol. 2019 Jul;24(7):836-841. doi: 10.1007/s10147-019-01414-0. Epub 2019 Feb 18.

PMID:
30778794
4.

Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer.

Sunakawa Y, Mogushi K, Lenz HJ, Zhang W, Tsuji A, Takahashi T, Denda T, Shimada K, Kochi M, Nakamura M, Kotaka M, Segawa Y, Tanioka H, Negoro Y, Moran M, Astrow SH, Hsiang J, Stephens C, Fujii M, Ichikawa W.

Mol Cancer Ther. 2018 Dec;17(12):2788-2795. doi: 10.1158/1535-7163.MCT-18-0694. Epub 2018 Oct 1.

PMID:
30275242
5.

Immune-related Genes to Dominate Neutrophil-lymphocyte Ratio (NLR) Associated With Survival of Cetuximab Treatment in Metastatic Colorectal Cancer.

Sunakawa Y, Yang D, Cao S, Zhang W, Moran M, Astrow SH, Hsiang J, Stephens C, Tsuji A, Takahashi T, Tanioka H, Negoro Y, Takagane A, Tani S, Yamaguchi T, Eto T, Fujii M, Ichikawa W, Lenz HJ.

Clin Colorectal Cancer. 2018 Dec;17(4):e741-e749. doi: 10.1016/j.clcc.2018.08.002. Epub 2018 Aug 23.

PMID:
30219280
6.

Cetuximab retreatment in patients with metastatic colorectal cancer who exhibited a clinical benefit in response to prior cetuximab: A retrospective study.

Tanioka H, Asano M, Yoshida R, Waki N, Uno F, Ishizaki M, Yamashita K, Morishita Y, Nagasaka T.

Oncol Lett. 2018 Sep;16(3):3674-3680. doi: 10.3892/ol.2018.9127. Epub 2018 Jul 11.

7.

A prospective Phase II study to examine the relationship between quality of life and adverse events of first-line chemotherapy plus cetuximab in patients with KRAS wild-type unresectable metastatic colorectal cancer: QUACK trial.

Iwamoto S, Ooki A, Morita S, Hara H, Tanioka H, Satake H, Kataoka M, Kotaka M, Kagawa Y, Nakamura M, Shingai T, Ishikawa M, Miyake Y, Sudo T, Hashiguchi Y, Yabuno T, Sakamoto J, Tsuji A, Ando M, Yamaguchi K.

Cancer Med. 2018 Sep;7(9):4217-4227. doi: 10.1002/cam4.1623. Epub 2018 Jul 26.

8.

[Introduction].

Yamaguchi Y, Katata Y, Okawaki M, Yamamura M, Tanioka H, Nagasaka T.

Gan To Kagaku Ryoho. 2018 Jul;45(7):1017-1020. Japanese.

PMID:
30042263
9.

An insurmountable NPY Y5 receptor antagonist exhibits superior anti-obesity effects in high-fat diet-induced obese mice.

Fukasaka Y, Nambu H, Tanioka H, Obata A, Tonomura M, Okuno T, Yukioka H.

Neuropeptides. 2018 Aug;70:55-63. doi: 10.1016/j.npep.2018.05.006. Epub 2018 May 17.

PMID:
29801968
10.

Prophylactic Effect of Dexamethasone on Regorafenib-Related Fatigue and/or Malaise: A Randomized, Placebo-Controlled, Double-Blind Clinical Study in Patients with Unresectable Metastatic Colorectal Cancer (KSCC1402/HGCSG1402).

Tanioka H, Miyamoto Y, Tsuji A, Asayama M, Shiraishi T, Yuki S, Kotaka M, Makiyama A, Shimokawa M, Shimose T, Masuda S, Yamaguchi T, Komatsu Y, Saeki H, Emi Y, Baba H, Oki E, Maehara Y; Kyushu Study Group of Clinical Cancer (KSCC).

Oncology. 2018;94(5):289-296. doi: 10.1159/000486624. Epub 2018 Mar 7.

PMID:
29514163
11.

Correction to: S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102).

Miyamoto Y, Tsuji A, Tanioka H, Maekawa S, Kawanaka H, Kitazono M, Oki E, Emi Y, Murakami H, Ogata Y, Saeki H, Shimokawa M, Natsugoe S, Akagi Y, Baba H, Maehara Y.

Int J Clin Oncol. 2018 Apr;23(2):402. doi: 10.1007/s10147-017-1212-0.

PMID:
29138948
12.

CEA Response and Depth of Response (DpR) to Predict Clinical Outcomes of First-Line Cetuximab Treatment for Metastatic Colorectal Cancer.

Sunakawa Y, Tsuji A, Denda T, Segawa Y, Negoro Y, Shimada K, Kochi M, Nakamura M, Kotaka M, Tanioka H, Takagane A, Tani S, Yamaguchi T, Watanabe T, Takeuchi M, Fujii M, Ichikawa W.

Target Oncol. 2017 Dec;12(6):787-794. doi: 10.1007/s11523-017-0527-0.

PMID:
29064002
13.

The existence of dead cells in donor corneal endothelium preserved with storage media.

Kitazawa K, Inatomi T, Tanioka H, Kawasaki S, Nakagawa H, Hieda O, Fukuoka H, Okumura N, Koizumi N, Iliakis B, Sotozono C, Kinoshita S.

Br J Ophthalmol. 2017 Dec;101(12):1725-1730. doi: 10.1136/bjophthalmol-2017-310913. Epub 2017 Oct 5.

PMID:
28982949
14.

Phase II trial of capecitabine plus modified cisplatin (mXP) as first-line therapy in Japanese patients with metastatic gastric cancer (KSCC1104).

Satake H, Iwatsuki M, Uenosono Y, Shiraishi T, Tanioka H, Saeki H, Sugimachi K, Kitagawa D, Shimokawa M, Oki E, Emi Y, Kakeji Y, Tsuji A, Akagi Y, Natsugoe S, Baba H, Maehara Y; Kyushu Study Group of Clinical Cancer.

Cancer Chemother Pharmacol. 2017 Jan;79(1):147-153. doi: 10.1007/s00280-016-3204-6. Epub 2016 Dec 10.

15.

Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study.

Tsuruta A, Yamashita K, Tanioka H, Tsuji A, Inukai M, Yamakawa T, Yamatsuji T, Yoshimitsu M, Toyota K, Yamano T, Nagasaka T, Okajima M.

Drug Des Devel Ther. 2016 Nov 23;10:3827-3835. eCollection 2016.

16.

Prognostic Impact of Primary Tumor Location on Clinical Outcomes of Metastatic Colorectal Cancer Treated With Cetuximab Plus Oxaliplatin-Based Chemotherapy: A Subgroup Analysis of the JACCRO CC-05/06 Trials.

Sunakawa Y, Ichikawa W, Tsuji A, Denda T, Segawa Y, Negoro Y, Shimada K, Kochi M, Nakamura M, Kotaka M, Tanioka H, Takagane A, Tani S, Yamaguchi T, Watanabe T, Takeuchi M, Fujii M, Nakajima T.

Clin Colorectal Cancer. 2017 Sep;16(3):e171-e180. doi: 10.1016/j.clcc.2016.09.010. Epub 2016 Oct 6.

PMID:
27856123
17.

The possible involvement of intestine-derived IgA1: a case of IgA nephropathy associated with Crohn's disease.

Terasaka T, Uchida HA, Umebayashi R, Tsukamoto K, Tanaka K, Kitagawa M, Sugiyama H, Tanioka H, Wada J.

BMC Nephrol. 2016 Sep 5;17(1):122. doi: 10.1186/s12882-016-0344-1.

18.
19.

S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102).

Miyamoto Y, Tsuji A, Tanioka H, Maekawa S, Kawanaka H, Kitazono M, Oki E, Emi Y, Murakami H, Ogata Y, Saeki H, Shimokawa M, Natsugoe S, Akagi Y, Baba H, Maehara Y.

Int J Clin Oncol. 2016 Aug;21(4):705-712. doi: 10.1007/s10147-015-0943-z. Epub 2016 Jan 8. Erratum in: Int J Clin Oncol. 2017 Nov 14;:.

PMID:
26746689
20.

[Prosthetic Valve Endocarditis using Immunosuppressive Agent for Atopic Dermatitis;Report of a Case].

Tanioka H, Iwata K, Marumoto A, Kaneko M.

Kyobu Geka. 2015 May;68(5):383-6. Japanese.

PMID:
25963789
21.

Emergency rescue endovascular stent grafting of ascending aorta to relieve life-threatening coronary obstruction in a case of acute aortic dissection.

Tauchi Y, Tanioka H, Kondoh H, Satoh H, Matsuda H.

Ann Thorac Surg. 2014 Dec;98(6):e131-3. doi: 10.1016/j.athoracsur.2014.08.059. Epub 2014 Dec 1.

PMID:
25468124
22.

Expression of the P2Y₂ receptor on the rat ocular surface during a 1-year rearing period.

Tanioka H, Kuriki Y, Sakamoto A, Katsuta O, Kawazu K, Nakamura M.

Jpn J Ophthalmol. 2014 Nov;58(6):515-21. doi: 10.1007/s10384-014-0342-4. Epub 2014 Sep 2.

PMID:
25179431
23.

Prevalence and outcomes of acute hepatitis B in Okayama, Japan, 2006-2010.

Wada N, Yasunaka T, Ikeda F, Nishina S, Korenaga M, Hino K, Fujioka S, Osawa T, Itoshima T, Kawanaka M, Yamada G, Kariyama K, Takayama H, Kubota J, Morimoto Y, Mizushima T, Yamashita H, Tanioka H, Negoro Y, Toshimori J, Kobashi H, Hirano A, Itano Y, Takaki A, Yamamoto K.

Acta Med Okayama. 2014;68(4):243-7.

24.

A comparison of glycosaminoglycan distributions, keratan sulphate sulphation patterns and collagen fibril architecture from central to peripheral regions of the bovine cornea.

Ho LT, Harris AM, Tanioka H, Yagi N, Kinoshita S, Caterson B, Quantock AJ, Young RD, Meek KM.

Matrix Biol. 2014 Sep;38:59-68. doi: 10.1016/j.matbio.2014.06.004. Epub 2014 Jul 11.

25.

Ocular toxicity of benzalkonium chloride homologs compared with their mixtures.

Okahara A, Tanioka H, Takada K, Kawazu K.

J Toxicol Pathol. 2013 Dec;26(4):343-9. doi: 10.1293/tox.2013-0022. Epub 2013 Dec 26.

26.

Degeneration of retinal on bipolar cells induced by serum including autoantibody against TRPM1 in mouse model of paraneoplastic retinopathy.

Ueno S, Nishiguchi KM, Tanioka H, Enomoto A, Yamanouchi T, Kondo M, Yasuma TR, Yasuda S, Kuno N, Takahashi M, Terasaki H.

PLoS One. 2013 Nov 25;8(11):e81507. doi: 10.1371/journal.pone.0081507. eCollection 2013.

27.

P2X₇ receptor activation may be involved in neuronal loss in the retinal ganglion cell layer after acute elevation of intraocular pressure in rats.

Sugiyama T, Lee SY, Horie T, Oku H, Takai S, Tanioka H, Kuriki Y, Kojima S, Ikeda T.

Mol Vis. 2013 Sep 28;19:2080-91. eCollection 2013.

28.

Identification of a novel benzimidazole derivative as a highly potent NPY Y5 receptor antagonist with an anti-obesity profile.

Tamura Y, Hayashi K, Omori N, Nishiura Y, Watanabe K, Tanaka N, Fujioka M, Kouyama N, Yukimasa A, Tanaka Y, Chiba T, Tanioka H, Nambu H, Yukioka H, Sato H, Okuno T.

Bioorg Med Chem Lett. 2013 Jan 1;23(1):90-5. doi: 10.1016/j.bmcl.2012.11.005. Epub 2012 Nov 10.

PMID:
23206862
29.

A study of host corneal endothelial cells after non-Descemet stripping automated endothelial keratoplasty.

Hatanaka H, Koizumi N, Okumura N, Takahashi H, Tanioka H, Young RD, Jones FE, Quantock AJ, Kinoshita S.

Cornea. 2013 Jan;32(1):76-80. doi: 10.1097/ICO.0b013e31825d568a.

PMID:
22968356
30.

Effect of taurine on acinar cell apoptosis and pancreatic fibrosis in dibutyltin dichloride-induced chronic pancreatitis.

Matsushita K, Mizushima T, Shirahige A, Tanioka H, Sawa K, Ochi K, Tanimoto M, Koide N.

Acta Med Okayama. 2012;66(4):329-34.

31.

Hit to lead SAR study on benzoxazole derivatives for an NPY Y5 antagonist.

Omori N, Kouyama N, Yukimasa A, Watanabe K, Yokota Y, Tanioka H, Nambu H, Yukioka H, Sato N, Tanaka Y, Sekiguchi K, Okuno T.

Bioorg Med Chem Lett. 2012 Mar 1;22(5):2020-3. doi: 10.1016/j.bmcl.2012.01.027. Epub 2012 Jan 18.

PMID:
22300657
32.

Tumor-associated calcium signal transducer 2 is required for the proper subcellular localization of claudin 1 and 7: implications in the pathogenesis of gelatinous drop-like corneal dystrophy.

Nakatsukasa M, Kawasaki S, Yamasaki K, Fukuoka H, Matsuda A, Tsujikawa M, Tanioka H, Nagata-Takaoka M, Hamuro J, Kinoshita S.

Am J Pathol. 2010 Sep;177(3):1344-55. doi: 10.2353/ajpath.2010.100149. Epub 2010 Jul 22.

33.

Structural collagen alterations in macular corneal dystrophy occur mainly in the posterior stroma.

Palka BP, Sotozono C, Tanioka H, Akama TO, Yagi N, Boote C, Young RD, Meek KM, Kinoshita S, Quantock AJ.

Curr Eye Res. 2010 Jul;35(7):580-6. doi: 10.3109/02713681003760150.

PMID:
20597644
34.

The relationship between preoperative clinical scores and immunohistological evaluation of surgically resected tissues in chronic severe ocular surface diseases.

Tanioka H, Kawasaki S, Sotozono C, Nakamura T, Inatomi T, Kinoshita S.

Jpn J Ophthalmol. 2010 Jan;54(1):66-73. doi: 10.1007/s10384-009-0770-8. Epub 2010 Feb 12.

PMID:
20151279
35.

[A case presenting peculiar staining with fluorescein on the unilateral cornea].

Kato H, Yokoi N, Tanioka H, Sotozono C, Hosotani Y, Kinoshita S.

Nippon Ganka Gakkai Zasshi. 2009 Sep;113(9):913-9. Japanese.

PMID:
19882929
36.

Basophils in the giant papillae of chronic allergic keratoconjunctivitis.

Matsuda A, Ebihara N, Yokoi N, Okayama Y, Watanabe Y, Kawasaki S, Tanioka H, Walls AF, Hamuro J, Kinoshita S, Murakami A.

Br J Ophthalmol. 2010 Apr;94(4):513-8. doi: 10.1136/bjo.2009.165316. Epub 2009 Oct 14.

PMID:
19828516
37.

Functional role of thymic stromal lymphopoietin in chronic allergic keratoconjunctivitis.

Matsuda A, Ebihara N, Yokoi N, Kawasaki S, Tanioka H, Inatomi T, de Waal Malefyt R, Hamuro J, Kinoshita S, Murakami A.

Invest Ophthalmol Vis Sci. 2010 Jan;51(1):151-5. doi: 10.1167/iovs.09-4183. Epub 2009 Sep 9.

PMID:
19741251
38.

Cultivated human conjunctival epithelial transplantation for total limbal stem cell deficiency.

Ang LP, Tanioka H, Kawasaki S, Ang LP, Yamasaki K, Do TP, Thein ZM, Koizumi N, Nakamura T, Yokoi N, Komuro A, Inatomi T, Nakatsukasa M, Kinoshita S.

Invest Ophthalmol Vis Sci. 2010 Feb;51(2):758-64. doi: 10.1167/iovs.09-3379. Epub 2009 Jul 30.

PMID:
19643956
39.

Usefulness of immature platelet fraction for the clinical evaluation of myelodysplastic syndromes.

Saigo K, Takenokuchi M, Imai J, Numata K, Isono S, Zenibayashi M, Tanioka H, Yoshioka T, Nishizawa A, Takada M, Nomura T, Kubota Y.

Lab Hematol. 2009;15(2):13-6. doi: 10.1532/LH96.09003.

PMID:
19561008
40.

The role of interleukin-33 in chronic allergic conjunctivitis.

Matsuda A, Okayama Y, Terai N, Yokoi N, Ebihara N, Tanioka H, Kawasaki S, Inatomi T, Katoh N, Ueda E, Hamuro J, Murakami A, Kinoshita S.

Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4646-52. doi: 10.1167/iovs.08-3365. Epub 2009 May 20.

PMID:
19458329
41.

Investigation of the corneal filament in filamentary keratitis.

Tanioka H, Yokoi N, Komuro A, Shimamoto T, Kawasaki S, Matsuda A, Kinoshita S.

Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3696-702. doi: 10.1167/iovs.08-2938. Epub 2009 May 14.

PMID:
19443713
42.

Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat diet.

Kusakabe T, Tanioka H, Ebihara K, Hirata M, Miyamoto L, Miyanaga F, Hige H, Aotani D, Fujisawa T, Masuzaki H, Hosoda K, Nakao K.

Diabetologia. 2009 Apr;52(4):675-83. doi: 10.1007/s00125-009-1258-2. Epub 2009 Jan 24.

PMID:
19169663
43.

Genomic aberrations and cellular heterogeneity in SV40-immortalized human corneal epithelial cells.

Yamasaki K, Kawasaki S, Young RD, Fukuoka H, Tanioka H, Nakatsukasa M, Quantock AJ, Kinoshita S.

Invest Ophthalmol Vis Sci. 2009 Feb;50(2):604-13. doi: 10.1167/iovs.08-2239. Epub 2008 Sep 29.

PMID:
18824731
44.

Cultivated corneal endothelial transplantation in a primate: possible future clinical application in corneal endothelial regenerative medicine.

Koizumi N, Sakamoto Y, Okumura N, Tsuchiya H, Torii R, Cooper LJ, Ban Y, Tanioka H, Kinoshita S.

Cornea. 2008 Sep;27 Suppl 1:S48-55. doi: 10.1097/ICO.0b013e31817f2298.

PMID:
18813075
45.

[Multiple endocrine neoplasm type 1-related gastrinomas: selective arterial calcium injection test for diagnosis of the location].

Meguri Y, Tanioka H, Kishimoto T.

Nihon Naika Gakkai Zasshi. 2008 Aug 10;97(8):1882-4. Japanese. No abstract available.

PMID:
18788421
46.

Diagnosis of multiple myeloma in a patient with atypical corneal findings.

Nakatsukasa M, Sotozono C, Tanioka H, Shimazaki C, Kinoshita S.

Cornea. 2008 Feb;27(2):249-51. doi: 10.1097/ICO.0b013e31815b82cd.

PMID:
18216590
47.

A thermoreversible hydrogel as a biosynthetic bandage for corneal wound repair.

Pratoomsoot C, Tanioka H, Hori K, Kawasaki S, Kinoshita S, Tighe PJ, Dua H, Shakesheff KM, Rose FR.

Biomaterials. 2008 Jan;29(3):272-81. Epub 2007 Oct 31.

PMID:
17976717
48.

Cultivated corneal endothelial cell sheet transplantation in a primate model.

Koizumi N, Sakamoto Y, Okumura N, Okahara N, Tsuchiya H, Torii R, Cooper LJ, Ban Y, Tanioka H, Kinoshita S.

Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4519-26.

PMID:
17898273
49.

Oral administration of taurine improves experimental pancreatic fibrosis.

Shirahige A, Mizushima T, Matsushita K, Sawa K, Ochi K, Ichimura M, Tanioka H, Shinji T, Koide N, Tanimoto M.

J Gastroenterol Hepatol. 2008 Feb;23(2):321-7. Epub 2007 Aug 30.

PMID:
17764527
50.

Assessment of epithelial integrity and cell viability in epithelial flaps prepared with the epi-LASIK procedure.

Tanioka H, Hieda O, Kawasaki S, Nakai Y, Kinoshita S.

J Cataract Refract Surg. 2007 Jul;33(7):1195-200.

PMID:
17586375

Supplemental Content

Loading ...
Support Center